Xenon Pharmaceuticals Stock Pattern Recognition Two Crows

XENE Stock  USD 36.73  0.29  0.78%   
Xenon Pharmaceuticals pattern recognition tool provides the execution environment for running the Two Crows recognition and other technical functions against Xenon Pharmaceuticals. Xenon Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Two Crows recognition function is designed to identify and follow existing trends. Xenon Pharmaceuticals momentum indicators are usually used to generate trading rules based on assumptions that Xenon Pharmaceuticals trends in prices tend to continue for long periods.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of fourty-nine. The function did not return any valid pattern recognition events for the selected time horizon. Two Crows is a 3-day pattern that warns about a possible future trend reversal for Xenon Pharmaceuticals.
JavaScript chart by amCharts 3.21.15Dec2025FebJan 27FebFeb 10Feb 17Feb 24Mar37.037.538.038.539.039.540.040.5 100K200K300K400K500K600K700K800K900K1M1.1M1.2M1.3M1.4M 43.1K43.2K43.3K43.4K43.5K43.6K43.7K43.8K43.9K44K44.1K44.2K44.3K44.4K44.5K44.6K44.7K44.8K44.9K Show all
JavaScript chart by amCharts 3.21.15Xenon Pharmaceuticals Volume Xenon Pharmaceuticals Closing Prices Dow Jones Industrial Closing Prices - Benchmark Xenon Pharmaceuticals Two Crows

Xenon Pharmaceuticals Technical Analysis Modules

Most technical analysis of Xenon Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Xenon from various momentum indicators to cycle indicators. When you analyze Xenon charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Xenon Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Xenon Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Xenon Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Xenon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Xenon Pharmaceuticals's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Xenon Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Xenon Pharmaceuticals, we also check how macroeconomic factors affect Xenon Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2022 2024 2025 (projected)
Days Sales Outstanding38.1534.3364.67
PTB Ratio3.314.043.27
Hype
Prediction
LowEstimatedHigh
34.9037.0539.20
Details
Intrinsic
Valuation
LowRealHigh
33.3245.0147.16
Details
Naive
Forecast
LowNextHigh
35.3037.4539.60
Details
16 Analysts
Consensus
LowTargetHigh
52.4857.6764.01
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Xenon Pharmaceuticals is a strong investment it is important to analyze Xenon Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xenon Pharmaceuticals' future performance. For an informed investment choice regarding Xenon Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenon Pharmaceuticals. If investors know Xenon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.01)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.21)
Return On Equity
(0.30)
The market value of Xenon Pharmaceuticals is measured differently than its book value, which is the value of Xenon that is recorded on the company's balance sheet. Investors also form their own opinion of Xenon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Xenon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Xenon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xenon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Trending Assets

MRUS
Merus BV
47.09  0.87  1.88 
INBX
Inhibrx
13.25  0.65  5.16 
ANAB
AnaptysBio
16.82  0.42  2.56 
KRON
Kronos Bio
0.98  0.02  2.08 
IDYA
Ideaya Biosciences
20.57  0.33  1.63 
ACLX
Arcellx
64.82  3.43  5.59 
MGTX
MeiraGTx Holdings PLC
7.13  0.15  2.15 
ASND
Ascendis Pharma AS
156.58  3.44  2.25 
CRNX
Crinetics Pharmaceuticals
35.78  2.57  7.74 
REPL
Replimune Group
12.68  0.04  0.32 
VTYX
Ventyx Biosciences
1.58  0.13  8.97 
VRDN
Viridian Therapeutics
15.53  0.24  1.57 
NUVL
Nuvalent
74.98  0.07  0.09 
KROS
Keros Therapeutics
11.08  0.07  0.64 
DYN
Dyne Therapeutics
13.61  0.44  3.34 
EWTX
Edgewise Therapeutics
26.17  -0.22  -0.83 
UTHR
United Therapeutics
320.05  -3.57  -1.1 
PCVX
Vaxcyte
73.02  -1.2  -1.62 
CYTK
Cytokinetics
46.00  -1.45  -3.06 
KRTX
Karuna Therapeutics
0.00  0.00  0.00